Read the article to learn more about Identification of Novel Selective CB2 Receptor Agonists Through CADD.
a Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
b Evotec (UK) Ltd, 114 Innovation Drive, Milton Park, Abingdon, Oxfordshire OX14 4RZ, United Kingdom
c Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany
